Nicholas Douzinas

Direct daily activities of a highly experienced team of 5 focused on providing client advisory recommendations, market analysis, order execution, and portfolio management to HNW clients. Elected to the Asset Investment Committee and partnered with the company’s Managing Director, the President of the Board of Directors, and the main shareholder to assess the development of company investments. Boosted percentage of foreign investments to total investments from 10% in 2008 to 45% in 2010.

Prepared, executed and analyzed Health Outcome data for clinical trials for Alzheimer’s disease from initial phases (phase 1 and 2) with a focus on the financial impact, work productivity and quality of life aspects of the compounds in question. Designed and implemented Global Health Outcomes strategies, studies and instruments that generated Health Outcomes Data.

Worked on marketing strategies for Antibiotics market in Greece. Represented company on Career days at Private Schools in Athens